Fonte: Cardiovascular Drugs and Therapy. Unidade: FM
Assuntos: FARMACOLOGIA CLÍNICA, CARDIOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERRANO JUNIOR, Carlos Vicente et al. Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes. Cardiovascular Drugs and Therapy, v. 17, p. 129-132, 2003Tradução . . Acesso em: 03 nov. 2024.APA
Serrano Junior, C. V., Nicolau, J. C., Venturinelli, M., Baracioli, L. P., Anders, R. J., Cannon, C. P., & Ramires, J. A. F. (2003). Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes. Cardiovascular Drugs and Therapy, 17, 129-132.NLM
Serrano Junior CV, Nicolau JC, Venturinelli M, Baracioli LP, Anders RJ, Cannon CP, Ramires JAF. Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes. Cardiovascular Drugs and Therapy. 2003 ; 17 129-132.[citado 2024 nov. 03 ]Vancouver
Serrano Junior CV, Nicolau JC, Venturinelli M, Baracioli LP, Anders RJ, Cannon CP, Ramires JAF. Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes. Cardiovascular Drugs and Therapy. 2003 ; 17 129-132.[citado 2024 nov. 03 ]
